Apeiron, Evotec, Sanofi team up on cancer immunotherapies
A few days after teaming up in a diabetes deal, Evotec AG and Sanofi signed a new agreement, this time involving Apeiron Biologics AG and focusing on cancer immunotherapies.
- Drug Discovery Tools
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com